查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629231

静脉 (IV)水合治疗市场，按成分、按应用、按最终用途、按国家和地区划分 - 2025-2032 年全球行业分析、市场规模、市场份额和预测

Intravenous (IV) Hydration Therapy Market, By Component, By Application, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 390 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2024 年，静脉 (IV)水合疗法市场规模为 26.7825 亿美元，2025 年至 2032 年复合年增长率为 8.1%。

静脉（IV）水合治疗市场-市场动态

脱水相关疾病盛行率上升推动市场成长

脱水相关疾病盛行率的上升是静脉水化治疗市场成长的重要驱动力。脱水可能由多种因素引起，包括过热、疾病、营养不良或剧烈的体力活动，并可能导致严重的併发症，如肾衰竭、中暑和电解质失衡。随着气候变迁、气温上升和热浪频率增加等全球健康挑战，脱水变得更加普遍，特别是在老年人、儿童和慢性病患者等弱势群体中。除了环境因素外，胃肠炎、糖尿病和慢性肾臟病等疾病也会导致脱水率升高，进一步增加了对有效水合疗法的需求。静脉水化治疗在紧急护理环境中至关重要，快速补充液体和电解质对于预防进一步的併发症至关重要。据世界卫生组织 (WHO) 称，脱水每年导致 130 万人死亡，其中很大一部分死亡发生在低收入和中等收入国家。人们对补液疗法重要性的认识不断提高，以及更先进的静脉补液解决方案的出现，预计将推动市场的扩张。

静脉 (IV)水合治疗市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球市场在预测期内（2025-2032 年）每年将以 8.1% 左右的复合年增长率成长
  • 根据组件细分，Mediated 预计将在 2024 年显示最大的市场份额
  • 根据最终用途细分，医院将成为 2024 年的主导职能
  • 按地区划分，北美是 2024 年的主要收入来源

静脉 (IV)水合疗法市场区隔分析：

全球静脉 (IV)水合治疗市场根据成分、应用、最终用途和地区进行细分。

市场依成分分为五类：药物和非药物。药物因其能够治疗特定的医疗状况（例如电解质失衡、感染和营养不良）并提供有针对性的治疗益处而在市场上占据主导地位。它们在重症监护环境中的有效性确保了医疗保健提供者的更高需求和偏好。

根据最终用途，市场分为三类：医院、健康中心和水疗中心以及家庭医疗保健。医院因其在提供紧急护理和重症监护方面的核心作用而占据市场主导地位，而快速补液对于患者的稳定至关重要。此外，医院拥有有效实施专门水合治疗的基础设施和资源。

静脉 (IV)水合治疗市场 - 地理洞察

由于先进的医疗设施、对紧急和重症护理服务的高需求以及对静脉水化疗法益处的广泛认识，北美占据了主导份额。尤其是在美国，用于医疗和健康目的的静脉补水的使用有所增加，包括用于管理中暑、流感和胃肠道问题等各种病症引起的脱水。德国和英国在医疗保健方面处于领先地位，越来越多的医院采用静脉水化疗法来照顾病人。由于医疗保健系统的改善、城市化进程的加快以及慢性病患病率的上升，亚太地区，特别是印度和中国，正在经历快速增长，导致对水合疗法的需求更高。由于医疗保健服务的改善以及人们对静脉补水在治疗脱水中的作用的认识不断提高，拉丁美洲和中东地区也出现了增长。

静脉（IV）水合治疗市场-竞争格局：

静脉（IV）水化治疗市场的竞争格局的特点是存在几个关键参与者，从成熟的製药公司到专门从事医疗保健解决方案的新兴新创公司。公司专注于策略合作伙伴关係、合併、收购和合作，以增强其产品供应并扩大其市场范围。除了大型製药公司之外，静脉输液服务的专业提供者也越来越受欢迎，直接向消费者提供服务，特别是在健康和门诊环境中。随着人们出于非医疗目的（例如宿醉恢復或提高运动表现）寻求水合疗法，这些服务越来越受到关注。此外，静脉注射技术的进步，例如智慧型输液帮浦和改进的液体配方，也有助于增强竞争动力。公司也投资研发，以针对特定医疗状况打造更有效、更专业的补水解决方案，进一步加剧市场竞争。由于市场受到严格监管，特别是在医疗保健领域，监管批准和遵守行业标准对于公司保持竞争优势至关重要。在不断增长的医疗保健需求、不断提高的意识和技术创新等因素的推动下，对静脉水化疗法的需求不断增长，导致了竞争环境，企业必须创新并适应不断变化的市场趋势。

最新进展：

  • 2024 年 4 月，Evocus 推出了全新水合产品 Evocus 水合 IV，旨在透过其独特的主动吸收技术提供快速的水平衡和增强的性能。这种电解质饮料混合物不含人工添加剂和咖啡因，针对寻求快速补水的个人，特别是那些生活方式活跃的人，包括运动员。它有多种口味可供选择，被定位为促进水分和肌肉恢復的更健康替代品，重点是改善身心健康。
  • 2024 年7 月，ChromaDex 宣布计划从8 月开始在领先的健康诊所首次推出其医药级静脉注射Niagen(R)（氯化烟酰胺核苷），为传统NAD+ IV 疗法提供更快、更有效的替代方案。这款新产品具有卓越的耐受性、更短的输注时间和更高的 NAD+ 血液水平，使其成为不断增长的静脉补液市场中一项有前途的创新。
  • 2024 年 4 月，美国顶级粉状补水品牌 Liquid IV 进军澳洲市场，推出水合 Multiplier 来解决当地的补水挑战。该产品非常注重健康，旨在比单纯喝水更快地改善水分，含有必需的维生素和电解质，并将在当地生产以满足不断增长的需求。联合利华于 2020 年收购 Liquid IV，推动了其国际成长，该产品现已在澳洲领先零售商处销售。

目录

第 1 章：静脉 (IV)水合疗法市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 静脉 (IV)水合疗法市场片段（按成分）
    • 静脉 (IV)水合疗法市场片段（按应用）
    • 按最终用途分類的静脉 (IV)水合疗法市场片段
    • 按国家/地区分類的静脉 (IV)水合疗法市场片段
    • 按地区分類的静脉 (IV)水合疗法市场片段
  • 竞争洞察

第 3 章：静脉 (IV)水合疗法主要市场趋势

  • 静脉 (IV)水合疗法市场驱动因素
    • 市场驱动因素的影响分析
  • 静脉 (IV)水合治疗市场限制
    • 市场限制影响分析
  • 静脉 (IV)水合治疗市场机会
  • 静脉（IV）水合治疗市场未来趋势

第 4 章：静脉 (IV)水合疗法产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：静脉 (IV)水合治疗市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：静脉 (IV)水合治疗市场格局

  • 2024 年静脉 (IV)水合疗法市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：静脉 (IV)水合治疗市场 - 按组成部分

  • 概述
    • 按组成部分分類的细分市场占有率分析
    • 药
    • 非药物

第 8 章：静脉 (IV)水合治疗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 免疫增强剂
    • 能量助推器
    • 皮肤护理
    • 偏头痛
    • 其他的

第 9 章：静脉 (IV)水合治疗市场 - 依最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院
    • 健康中心和水疗中心
    • 家庭医疗保健

第 10 章：静脉 (IV)水合治疗市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美静脉 (IV)水合疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按组成部分）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用途）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲静脉 (IV)水合疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按组成部分）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用途）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区静脉 (IV)水合疗法主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按组成部分）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用途）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲静脉 (IV)水合疗法主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按组成部分）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲静脉 (IV)水合疗法主要製造商
    • MEA 市场规模和预测（按国家/地区）
    • MEA 市场规模和预测（按组成部分）
    • MEA 市场规模和预测（按应用）
    • MEA 市场规模和预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 静脉 (IV)水合治疗产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Baxter International
    • Fresenius Kabi
    • B. Braun Melsungen AG
    • Pfizer company
    • Otsuka Pharmaceutical
    • Terumo Corporation
    • Medline Industries
    • Sagent Pharmaceuticals
    • Amgen
    • Vifor Pharma
    • ICU Medical
    • Chugai Pharmaceutical
    • Cipla
    • Zhejiang Hisun Pharmaceutical
    • Viatris
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4560

REPORT HIGHLIGHT

Intravenous (IV) Hydration Therapy Market size was valued at US$ 2,678.25 Million in 2024, expanding at a CAGR of 8.1% from 2025 to 2032.

Intravenous (IV) hydration therapy involves the administration of fluids directly into a patient's bloodstream through an IV line. This method ensures rapid delivery of fluids, electrolytes, and nutrients, bypassing the digestive system for immediate absorption. IV hydration therapy is commonly used in medical settings to treat dehydration caused by conditions like vomiting, diarrhea, fever, or excessive heat exposure. It is also vital for patients recovering from surgery, illnesses, or those with chronic conditions that impair fluid absorption. The need for IV hydration therapy arises when the body cannot adequately absorb or retain fluids orally, or when rapid rehydration is necessary. It is crucial in situations where oral hydration is not effective or feasible, such as in cases of severe dehydration or electrolyte imbalances. By replenishing lost fluids and electrolytes, IV hydration helps restore normal body functions, ensuring proper circulation, temperature regulation, and nutrient transport. The importance of IV hydration therapy lies in its ability to stabilize critical patients quickly and efficiently. It prevents complications such as kidney failure, shock, and organ dysfunction that can arise from severe dehydration. Additionally, IV therapy supports recovery and enhances overall well-being, especially in emergency care, post-operative recovery, and intensive care units.

Intravenous (IV) Hydration Therapy Market- Market Dynamics

Rising Prevalence of dehydration-related conditions to drive the market growth

The rising prevalence of dehydration-related conditions is a significant driver for the growth of the IV hydration therapy market. Dehydration can result from various factors, including excessive heat, illness, malnutrition, or intense physical activity, and can lead to severe complications such as kidney failure, heat stroke, and electrolyte imbalances. With global health challenges like climate change, rising temperatures, and the increasing frequency of heatwaves, dehydration has become more common, particularly in vulnerable populations like the elderly, children, and those with chronic illnesses. In addition to environmental factors, conditions such as gastroenteritis, diabetes, and chronic kidney disease contribute to higher dehydration rates, further increasing the need for effective hydration therapies. IV hydration therapy is essential in emergency care settings, where rapid fluid and electrolyte replenishment are critical to preventing further complications. According to the World Health Organization (WHO), dehydration is responsible for 1.3 million deaths annually, with a large percentage of these deaths occurring in low- and middle-income countries. The growing awareness of the importance of rehydration therapies and the availability of more advanced IV hydration solutions are expected to drive the market's expansion.

Intravenous (IV) Hydration Therapy Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2025-2032)
  • Based on Component segmentation, Medicated was predicted to show maximum market share in the year 2024
  • Based on End-Use segmentation, Hospitals was the leading Function in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Intravenous (IV) Hydration Therapy Market- Segmentation Analysis:

The Global Intravenous (IV) Hydration Therapy Market is segmented on the basis of Component, Application, End-Use and Region.

The market is divided into five categories based on Component: Medicated and Non-Medicated. Medicated dominate the market due to their ability to treat specific medical conditions, such as electrolyte imbalances, infections, and malnutrition, offering targeted therapeutic benefits. Their effectiveness in critical care settings ensures higher demand and preference among healthcare providers.

The market is divided into three categories based on End-Use: Hospitals, Wellness Centres & Spas, and Home Healthcare. Hospitals dominate the market due to their central role in providing emergency and intensive care, where rapid rehydration is crucial for patient stabilization. Additionally, hospitals have the infrastructure and resources to administer specialized hydration treatments effectively.

Intravenous (IV) Hydration Therapy Market- Geographical Insights

North America holds a dominant share due to advanced healthcare facilities, high demand for emergency and critical care services, and widespread awareness about the benefits of IV hydration therapy. The U.S., in particular, has seen an increase in the use of IV hydration for medical and wellness purposes, including for managing dehydration from various conditions like heat stroke, flu, and gastrointestinal issues.In Europe, the market is growing steadily, with countries like Germany and the UK leading in healthcare advancements and a rising number of hospitals adopting IV hydration therapy for patient care. The Asia-Pacific region, particularly India and China, is experiencing rapid growth due to improving healthcare systems, rising urbanization, and an increasing prevalence of chronic diseases, leading to higher demand for hydration therapies. Latin America and the Middle East are also witnessing growth, driven by improvements in healthcare access and rising awareness of IV hydration's role in treating dehydration.

Intravenous (IV) Hydration Therapy Market- Competitive Landscape:

The competitive landscape of the intravenous (IV) hydration therapy market is characterized by the presence of several key players, ranging from established pharmaceutical companies to emerging startups specializing in healthcare solutions. Companies are focusing on strategic partnerships, mergers, acquisitions, and collaborations to enhance their product offerings and expand their market reach. In addition to large pharmaceutical firms, specialized providers of IV hydration services are gaining popularity, offering services directly to consumers, particularly in wellness and outpatient settings. These services are gaining traction as people seek hydration therapies for non-medical purposes, such as hangover recovery or athletic performance enhancement. Furthermore, advancements in IV infusion technologies, such as smart infusion pumps and improved fluid formulations, are contributing to the competitive dynamics. Companies are also investing in research and development to create more effective and specialized hydration solutions tailored to specific medical conditions, further fueling market competition. Regulatory approvals and compliance with industry standards are essential for companies to maintain a competitive edge, as the market is heavily regulated, particularly in healthcare settings. The increasing demand for IV hydration therapy, driven by factors like rising healthcare needs, growing awareness, and technological innovations, has resulted in a competitive environment where companies must innovate and adapt to evolving market trends.

Recent Developments:

  • In April 2024, Evocus launched its new hydration product, Evocus Hydration IV, designed to offer rapid water balance and enhanced performance with its unique Active Absorption Technology. This electrolyte drink mix, free from artificial additives and caffeine, is targeted at individuals seeking quick hydration, particularly those with active lifestyles, including athletes. Available in multiple flavors, it is positioned as a healthier alternative for boosting hydration and muscle recovery, with a focus on improving both physical and mental well-being.
  • In July 2024, ChromaDex announced plans to debut its pharmaceutical-grade intravenous Niagen(R) (nicotinamide riboside chloride) at leading wellness clinics starting in August, offering a faster, more effective alternative to traditional NAD+ IV therapies. The new product promises superior tolerability, a shorter infusion time, and a higher rise in NAD+ blood levels, making it a promising innovation in the growing intravenous hydration market.
  • In April 2024, Liquid I.V., the top powdered hydration brand in the U.S., expanded into the Australian market, offering its Hydration Multiplier to address local hydration challenges. With a strong focus on wellness, the product aims to improve hydration faster than water alone, featuring essential vitamins and electrolytes, and will be manufactured locally to meet growing demand. Unilever's acquisition of Liquid I.V. in 2020 has fueled its international growth, with the product now available in leading Australian retailers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Baxter International
  • Fresenius Kabi
  • B. Braun Melsungen AG
  • Pfizer company
  • Otsuka Pharmaceutical
  • Terumo Corporation
  • Medline Industries
  • Sagent Pharmaceuticals
  • Amgen
  • Vifor Pharma
  • ICU Medical
  • Chugai Pharmaceutical
  • Cipla
  • Zhejiang Hisun Pharmaceutical
  • Viatris
  • Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Medicated
  • Non-medicated

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Others

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Wellness Centres & Spas
  • Home Healthcare

GLOBAL INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Intravenous (IV) Hydration Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Intravenous (IV) Hydration Therapy Market Snippet by Component
    • 2.1.2. Intravenous (IV) Hydration Therapy Market Snippet by Application
    • 2.1.3. Intravenous (IV) Hydration Therapy Market Snippet by End-Use
    • 2.1.4. Intravenous (IV) Hydration Therapy Market Snippet by Country
    • 2.1.5. Intravenous (IV) Hydration Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Intravenous (IV) Hydration Therapy Key Market Trends

  • 3.1. Intravenous (IV) Hydration Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Intravenous (IV) Hydration Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Intravenous (IV) Hydration Therapy Market Opportunities
  • 3.4. Intravenous (IV) Hydration Therapy Market Future Trends

4. Intravenous (IV) Hydration Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Intravenous (IV) Hydration Therapy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Intravenous (IV) Hydration Therapy Market Landscape

  • 6.1. Intravenous (IV) Hydration Therapy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Intravenous (IV) Hydration Therapy Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Medicated
    • 7.1.3. Non-medicated

8. Intravenous (IV) Hydration Therapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Immune Boosters
    • 8.1.3. Energy Boosters
    • 8.1.4. Skin Care
    • 8.1.5. Migraine
    • 8.1.6. Others

9. Intravenous (IV) Hydration Therapy Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Wellness Centres & Spas
    • 9.1.4. Home Healthcare

10. Intravenous (IV) Hydration Therapy Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Intravenous (IV) Hydration Therapy Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Intravenous (IV) Hydration Therapy Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Intravenous (IV) Hydration Therapy Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Baxter International
    • 11.2.2. Fresenius Kabi
    • 11.2.3. B. Braun Melsungen AG
    • 11.2.4. Pfizer company
    • 11.2.5. Otsuka Pharmaceutical
    • 11.2.6. Terumo Corporation
    • 11.2.7. Medline Industries
    • 11.2.8. Sagent Pharmaceuticals
    • 11.2.9. Amgen
    • 11.2.10. Vifor Pharma
    • 11.2.11. ICU Medical
    • 11.2.12. Chugai Pharmaceutical
    • 11.2.13. Cipla
    • 11.2.14. Zhejiang Hisun Pharmaceutical
    • 11.2.15. Viatris
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us